Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Harris Poll Finds Large Boost in Pharma Industry Reputation
Posted on March 15th, 2021 by Ann-Marie Roche in Pharma R&D
As the COVID-19 vaccine roll-out gains in intensity, it has become common to hear people toss out the names of pharmaceutical companies like Pfizer, Moderna and AstraZeneca with the same ease that they refer to their favorite brands of ketchup or peanut butter. This isn’t typical. While direct-to-consumer advertising has perhaps increased some awareness of drug makers, the pandemic has made pharma R&D a subject of public interest in an unprecedented fashion.
(more…)What Excites You Most About the Life Sciences Industry in 2021?
Posted on February 19th, 2021 by Ann-Marie Roche in Pharma R&D
We have looked back at some of the biggest advances in 2020, but it’s a new year and time to look ahead, so we asked our Life Sciences team what they are looking forward to in 2021.
(more…)What Were the Biggest Advances in Life Sciences in 2020?
Posted on February 8th, 2021 by Ann-Marie Roche in Pharma R&D
As we settle into a new year, it’s always good to take a moment to consider what was accomplished in the previous one. That’s why we asked members of Elsevier’s Life Sciences team what they felt were among the most noteworthy advances in the life sciences in 2020.
(more…)Looking at Emerging Trends in Telemedicine
Posted on December 17th, 2020 by Thea Howe in Pharma R&D
Telemedicine, once an intriguing proposition struggling to reach its potential, became an absolute necessity in 2020. In the early days of COVID-19, as medical centers labored to deal with an influx of patients while also trying to mitigate coronavirus spread, telemedicine was urgently needed as an option for providing healthcare to others at a safe distance. In the U.S., the government and providers quickly started to take measures to facilitate its use during the crisis of the pandemic.
(more…)
